ARCO – Associazione per la Ricerca e Cura dell’Orticaria (Italy)
National organization based in Milan, Italy and RUNTS registered. They have obtained the omalizumab therapeutic plan for 12 months and ad libitum according to clinical prescription. They also created networks of clinicians throughout Italy who, together with the association, promote research and treatment of urticaria. They have activated numerous projects at regional and national level for scientific dissemination related to urticaria and for the improvement of therapies and services for Italian urticaria sufferers. They actively collaborate with UCare Centers whose leaders are members of its Scientific Committee and is an independent association formed by patients.